Inflammatory Bowel Disease Treatment Market Size, Share, Analysis, Trends, Growth, 2032
Inflammatory Bowel Disease Treatment Market: by Type (Crohn’s Disease, and Ulcerative Colitis), by Route of Administration (Injectables [TNF-Inhibitors, IL Inhibitors, Anti-integrin, and Others], and Oral [ASAs, Corticosteroids, JAK Inhibitors, and Others]), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032-
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.16 Billion | USD 3.67 Billion | 6.04% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Inflammatory Bowel Disease Treatment Market, 2016 - 2025, (USD Billion)
- 2.2. Inflammatory Bowel Disease Treatment Market: Market Snapshot
- Chapter 3. Global Inflammatory Bowel Disease Treatment Market - Industry Analysis
- 3.1. Inflammatory Bowel Disease Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Rising prevalence of Crohn's disease and ulcerative colitis
- 3.2.2. Strong pipeline products
- 3.2.3. Growth in biosimilar drugs
- 3.2.4. Involvement of regulatory bodies for funding and designation
- 3.3. Restraints
- 3.3.1. High cost of treatment
- 3.3.2. Lack of early diagnosis
- 3.4. Opportunity
- 3.4.1. Potential growth opportunities in developing countries
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by type segment
- 3.6.2. Market attractiveness analysis by route of administration segment
- 3.6.3. Market attractiveness analysis by distribution channel segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global Inflammatory Bowel Disease Treatment Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global inflammatory bowel disease treatment market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New product launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Inflammatory Bowel Disease Treatment Market - Type Segment Analysis
- 5.1. Global inflammatory bowel disease treatment market overview: by type
- 5.1.1. Global inflammatory bowel disease treatment market revenue share, by type, 2018 and 2025
- 5.2. Crohn's Disease
- 5.2.1. Global inflammatory bowel disease treatment market by Crohn's disease, 2016 - 2025 (USD Billion)
- 5.3. Ulcerative Colitis
- 5.3.1. Global inflammatory bowel disease treatment market by ulcerative colitis, 2016 - 2025 (USD Billion)
- 5.1. Global inflammatory bowel disease treatment market overview: by type
- Chapter 6. Global Inflammatory Bowel Disease Treatment Market - Route of Administration Segment Analysis
- 6.1. Global inflammatory bowel disease treatment market overview: by route of administration
- 6.1.1. Global inflammatory bowel disease treatment market revenue share, by route of administration, 2018 and 2025
- 6.2. Injectables
- 6.2.1. Global inflammatory bowel disease treatment market by injectables, 2016 - 2025 (USD Billion)
- 6.2.2. TNF-inhibitors
- 6.2.2.1. Global TNF-inhibitors in inflammatory bowel disease treatment market by injectables, 2016 - 2025 (USD Billion)
- 6.2.3. IL inhibitors
- 6.2.3.1. Global IL inhibitors in inflammatory bowel disease treatment market by injectables, 2016 - 2025 (USD Billion)
- 6.2.4. Anti-integrin
- 6.2.4.1. Global anti-integrin in inflammatory bowel disease treatment market by injectables, 2016 - 2025 (USD Billion)
- 6.2.5. Others
- 6.2.5.1. Global others in inflammatory bowel disease treatment market by injectables, 2016 - 2025 (USD Billion)
- 6.3. Oral
- 6.3.1. Global inflammatory bowel disease treatment market by oral, 2016 - 2025 (USD Billion)
- 6.3.2. ASAs
- 6.3.2.1. Global ASAs in inflammatory bowel disease treatment market by oral, 2016 - 2025 (USD Billion)
- 6.3.3. Corticosteroids
- 6.3.3.1. Global corticosteroids in inflammatory bowel disease treatment market by oral, 2016 - 2025 (USD Billion)
- 6.3.4. JAK Inhibitors
- 6.3.4.1. Global JAK inhibitors in inflammatory bowel disease treatment market by oral, 2016 - 2025 (USD Billion)
- 6.3.5. Others
- 6.3.5.1. Global others in inflammatory bowel disease treatment market by oral, 2016 - 2025 (USD Billion)
- 6.1. Global inflammatory bowel disease treatment market overview: by route of administration
- Chapter 7. Global Inflammatory Bowel Disease Treatment Market - Distribution Channel Segment Analysis
- 7.1. Global inflammatory bowel disease treatment market overview: by distribution channel
- 7.1.1. Global inflammatory bowel disease treatment market revenue share, by distribution channel, 2018 and 2025
- 7.2. Hospital Pharmacy
- 7.2.1. Global inflammatory bowel disease treatment market by hospital pharmacy, 2016 - 2025 (USD Billion)
- 7.3. Retail Pharmacy
- 7.3.1. Global inflammatory bowel disease treatment market by retail pharmacy, 2016 - 2025 (USD Billion)
- 7.4. Online Pharmacy
- 7.4.1. Global inflammatory bowel disease treatment market by online pharmacy, 2016 - 2025 (USD Billion)
- 7.1. Global inflammatory bowel disease treatment market overview: by distribution channel
- Chapter 8. Global Inflammatory Bowel Disease Treatment Market - Regional Analysis
- 8.1. Global inflammatory bowel disease treatment market overview: by region
- 8.1.1. Global inflammatory bowel disease treatment market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America inflammatory bowel disease treatment market, by country, 2016 - 2025 (USD Billion)
- 8.2.2. North America inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.2.3. North America inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.2.4. North America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.2.5.2. The U.S. inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.2.5.3. The U.S. inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.2.6.2. Rest of North America inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.2.6.3. Rest of North America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe inflammatory bowel disease treatment market, by country, 2016 - 2025 (USD Billion)
- 8.3.2. Europe inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.3.3. Europe inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.3.4. Europe inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.3.5. U.K.
- 8.3.5.1. U.K. inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.3.5.2. U.K. inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.3.5.3. U.K. inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.3.6. Germany
- 8.3.6.1. Germany inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.3.6.2. Germany inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.3.6.3. Germany inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.3.7. France
- 8.3.7.1. France inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.3.7.2. France inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.3.7.3. France inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.3.8.2. Rest of Europe inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.3.8.3. Rest of Europe inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific inflammatory bowel disease treatment market, by country, 2016 - 2025 (USD Billion)
- 8.4.2. Asia Pacific inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.4.3. Asia Pacific inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.4.4. Asia Pacific inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.4.5.2. China inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.4.5.3. China inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.4.6.2. Japan inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.4.6.3. Japan inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.4.7.2. India inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.4.7.3. India inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America inflammatory bowel disease treatment market, by country, 2016 - 2025 (USD Billion)
- 8.5.2. Latin America inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.5.3. Latin America inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.5.4. Latin America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.5.5.2. Brazil inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.5.5.3. Brazil inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.5.6.2. Rest of Latin America inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.5.6.3. Rest of Latin America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa inflammatory bowel disease treatment market, 2016 - 2025 (USD Billion)
- 8.6.2. Middle East & Africa inflammatory bowel disease treatment market revenue, by type, 2016 - 2025 (USD Billion)
- 8.6.3. Middle East & Africa inflammatory bowel disease treatment market revenue, by route of administration, 2016 - 2025 (USD Billion)
- 8.6.4. Middle East & Africa inflammatory bowel disease treatment market revenue, by distribution channel, 2016 - 2025 (USD Billion)
- 8.1. Global inflammatory bowel disease treatment market overview: by region
- Chapter 9. Company Profiles
- 9.1. Sanofi S.A.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Abbott Laboratories
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Johnson & Johnson
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Pfizer, Inc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Biocon Ltd.
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. F. Hoffmann-La Roche AG
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. Takeda Pharmaceutical
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Quest Medical, Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Novartis AG
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. Mylan Pharmaceuticals Ltd.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.1. Sanofi S.A.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global inflammatory bowel disease treatment market, 2016 - 2025 (USD Billion)
4. Porter’s five forces analysis: inflammatory bowel disease treatment market
5. Global inflammatory bowel disease treatment market attractiveness, by type
6. Global inflammatory bowel disease treatment market attractiveness, by route of administration
7. Global inflammatory bowel disease treatment market attractiveness, by distribution channel
8. Global inflammatory bowel disease treatment market revenue share, by type, 2018 and 2025
9. Global inflammatory bowel disease treatment market by Crohn’s disease, 2016 - 2025 (USD Billion)
10. Global inflammatory bowel disease treatment market by ulcerative colitis, 2016 - 2025 (USD Billion)
11. Global inflammatory bowel disease treatment market revenue share, by route of administration, 2018 and 2025
12. Global inflammatory bowel disease treatment market by injectables, 2016 - 2025 (USD Billion)
13. Global inflammatory bowel disease treatment market by oral, 2016 - 2025 (USD Billion)
14. Global inflammatory bowel disease treatment market revenue share, by distribution channel, 2018 and 2025
15. Global inflammatory bowel disease treatment market by hospital pharmacy, 2016 - 2025 (USD Billion)
16. Global inflammatory bowel disease treatment market by retail pharmacy, 2016 - 2025 (USD Billion)
17. Global inflammatory bowel disease treatment market by online pharmacy, 2016 - 2025 (USD Billion)
18. Global inflammatory bowel disease treatment market revenue share, by region, 2018 & 2025
19. North America inflammatory bowel disease treatment market, 2016 - 2025 (USD Billion)
20. Europe inflammatory bowel disease treatment market, 2016 - 2025 (USD Billion)
21. Asia Pacific inflammatory bowel disease treatment market, 2016 – 2025 (USD Billion)
22. Latin America inflammatory bowel disease treatment market, 2016 - 2025 (USD Billion)
23. Middle East & Africa inflammatory bowel disease treatment market, 2016 – 2025 (USD Billion)
Table Of Tables
List of Tables
1. Global inflammatory bowel disease treatment market: snapshot
2. Drivers for inflammatory bowel disease treatment market: impact analysis
3. Restraints for inflammatory bowel disease treatment market: impact analysis
4. North America inflammatory bowel disease treatment market revenue, by country, 2016 – 2025 (USD Billion)
5. North America inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
6. North America inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
7. North America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
8. The U.S. inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
9. The U.S. inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
10. The U.S. inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
11. Rest of North America inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
12. Rest of North America inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
13. Rest of North America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
14. Europe inflammatory bowel disease treatment market revenue, by country, 2016 – 2025 (USD Billion)
15. Europe inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
16. Europe inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
17. Europe inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
18. U.K. inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
19. U.K. inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
20. U.K. inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
21. Germany inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
22. Germany inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
23. Germany inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
24. France inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
25. France inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
26. France inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
27. Rest of Europe inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
28. Rest of Europe inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
29. Rest of Europe inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
30. Asia Pacific inflammatory bowel disease treatment market revenue, by country, 2016 – 2025 (USD Billion)
31. Asia Pacific inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
32. Asia Pacific inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
33. Asia Pacific inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
34. China inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
35. China inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
36. China inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
37. Japan inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
38. Japan inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
39. Japan inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
40. India inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
41. India inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
42. India inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
43. Rest of Asia Pacific inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
44. Rest of Asia Pacific inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
45. Rest of Asia Pacific inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
46. Latin America inflammatory bowel disease treatment market revenue, by country, 2016 – 2025 (USD Billion)
47. Latin America inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
48. Latin America inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
49. Latin America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
50. Brazil inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
51. Brazil inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
52. Brazil inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
53. Rest of Latin America inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
54. Rest of Latin America inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
55. Rest of Latin America inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
56. Middle East & Africa inflammatory bowel disease treatment market revenue, by type, 2016 – 2025 (USD Billion)
57. Middle East & Africa inflammatory bowel disease treatment market revenue, by route of administration, 2016 – 2025 (USD Billion)
58. Middle East & Africa inflammatory bowel disease treatment market revenue, by distribution channel, 2016 – 2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Inflammatory bowel disease (IBD) is generally caused when the immune system attacks harmless virus, bacteria, or food in the intestine.
The global inflammatory bowel disease treatment market size accrued earnings worth approximately USD 2.16 Billion in 2023 and is predicted to gain revenue of about USD 3.67 Billion by 2032
The CAGR value of the inflammatory bowel disease treatment market is expected to be around 6.04% between 2024 and 2023.
North America held major share of the market for inflammatory bowel disease treatment in 2023 due to high prevalence rate of Crohn’s disease and ulcerative colitis, and rising geriatric population base in this region.
Some key players of the global inflammatory bowel disease treatment market are Sanofi S.A., Abbott Laboratories, Johnson & Johnson, Pfizer Inc., Biocon Ltd, F. Hoffmann-La Roche AG, Takeda Pharmaceutical, Quest Medical Inc., Novartis AG, and Mylan Pharmaceuticals Ltd.
The global inflammatory bowel disease treatment market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
